{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T14:04:29Z","timestamp":1761401069418},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[1998,10,1]],"date-time":"1998-10-01T00:00:00Z","timestamp":907200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[1998,10]]},"DOI":"10.1016\/s0022-510x(98)00201-9","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T12:14:01Z","timestamp":1027599241000},"page":"S69-S72","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S1","title":["Riluzole has no acute effect on motor unit parameters in ALS"],"prefix":"10.1016","volume":"160","author":[{"given":"Joy","family":"Desai","sequence":"first","affiliation":[]},{"given":"Mohamad","family":"Sharief","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Swash","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0022-510X(98)00201-9_BIB1","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/0028-3908(85)90196-0","article-title":"2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid transmission-II: biochemical properties","volume":"24","author":"Benavides","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/BF00370302","article-title":"Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre","volume":"419","author":"Benoit","year":"1991","journal-title":"Pflugers Arch."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB3","doi-asserted-by":"crossref","unstructured":"Bensimon G, Lacomblez L, Meininger V, ALS\/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. New Engl J Med 1994;330;585\u2013591.","DOI":"10.1056\/NEJM199403033300901"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/00003495-199652040-00010","article-title":"Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis","volume":"52","author":"Bryson","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/(SICI)1097-4598(199803)21:3<336::AID-MUS7>3.0.CO;2-B","article-title":"Fasciculation potentials in amyotrophic lateral sclerosis and other neurogenic disorders: a comparative electrophysiological investigation","volume":"21","author":"Carvalho","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB6","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi","year":"1988","journal-title":"Neuron"},{"issue":"Suppl. 1","key":"10.1016\/S0022-510X(98)00201-9_BIB7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0022-510X(97)00243-8","article-title":"Fasciculations: What do we know of their significance","volume":"152","author":"Desai","year":"1997","journal-title":"J. Neurol. Sci."},{"issue":"Suppl 4","key":"10.1016\/S0022-510X(98)00201-9_BIB8","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","article-title":"The pharmacology and mechanism of action of riluzole","volume":"47","author":"Doble","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB9","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1523\/JNEUROSCI.07-09-02910.1987","article-title":"Excitatory amino acid-induced release of 3H-GABA from cultured mouse cerebral cortex interneurons","volume":"7","author":"Drejer","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB10","doi-asserted-by":"crossref","unstructured":"El Escorial World Federation. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124;(Suppl.);96\u2013107.","DOI":"10.1016\/0022-510X(94)90191-0"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(95)00186-O","article-title":"Protective effect of riluzole on excitatory amino acid mediated neurotoxicity on motoneuron-enriched cultures","volume":"280","author":"Estevez","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl","key":"10.1016\/S0022-510X(98)00201-9_BIB12","first-page":"583P","article-title":"Riluzole antagonizes excitatory amino-acid-evoked firing in rat facial motoneurons in-vivo","volume":"97","author":"Girdlestone","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB13","first-page":"1055","article-title":"Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole","volume":"45","author":"Herbert","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1476-5381.1994.tb16203.x","article-title":"Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action","volume":"113","author":"Hubert","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB15","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/jnnp.52.12.1375","article-title":"Fasciculations in motor neuron disease: discharge rate reflects extent and recency of collateral sprouting","volume":"52","author":"Janko","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB16","first-page":"349","article-title":"Selective blockade of N-Methyl-D-Aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: Relationship with phencyclidine-like behavioral effects","volume":"252","author":"Koek","year":"1990","journal-title":"J. Pharamacol. Exp. Ther."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB17","doi-asserted-by":"crossref","unstructured":"Lacomblez L, Bensimon G, Leigh PN, ALS\/Riluzole Study Group II. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996;347;1425\u20131431.","DOI":"10.1016\/S0140-6736(96)91680-3"},{"key":"10.1016\/S0022-510X(98)00201-9_BIB18","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/ana.410220503","article-title":"Abnormal glutamate metabolism in amyotrophic lateral sclerosis","volume":"22","author":"Plaitakis","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.410240314","article-title":"The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis","volume":"24","author":"Plaitakis","year":"1988","journal-title":"Ann. Neurol."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB20","unstructured":"Rh\u00f4ne-Poulenc Rorer. Riluzole prescribing information. Collegeville, PA, USA, 1996."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB21","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"New Engl. J. Med."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB22","first-page":"7","article-title":"Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis","volume":"68","author":"Rothstein","year":"1995","journal-title":"Adv. Neurol."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","article-title":"Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis","volume":"38","author":"Rothstein","year":"1995","journal-title":"Ann. Neurol."},{"issue":"Suppl","key":"10.1016\/S0022-510X(98)00201-9_BIB24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0022-510X(94)90170-8","article-title":"Excitotoxicity and motor neurone disease: a review of the evidence","volume":"124","author":"Shaw","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB25","unstructured":"Stalberg E. Electrophysiological studies of reinnervation in ALS. In: Rowland LP, editor. Human motor neuron diseases. New York: Raven Press, 1982:47\u201359."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB26","unstructured":"Stalberg E, Sanders D. The motor unit in ALS studied with different neurophysiological techniques. In: Rose FC, editor. Research progress in motor neuron disease. London: Pitman, 1984:105\u2013122."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB27","unstructured":"Swash M, Schwartz MS. Staging motor neuron disease; single fibre EMG studies of asymmetry, progression and compensatory reinnervation. In: Rose FC, editor. Research progress in motor neuron disease. London: Pitman 1984:123\u2013140."},{"issue":"Suppl 13","key":"10.1016\/S0022-510X(98)00201-9_BIB28","first-page":"251","article-title":"Malignant and benign fasciculations","volume":"41","author":"Trojaborg","year":"1965","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/S0022-510X(98)00201-9_BIB29","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/106002809703100614","article-title":"Riluzole: A new agent for amyotrophic lateral sclerosis","volume":"31","author":"Wagner","year":"1997","journal-title":"Ann. Pharmacother."},{"issue":"3","key":"10.1016\/S0022-510X(98)00201-9_BIB30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0168-5597(94)90036-1","article-title":"Fasciculation potentials in foot and leg muscles of healthy young adults","volume":"93","author":"Van der Heijden","year":"1994","journal-title":"Electroencephalogr. Clin. Neurophysiol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X98002019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X98002019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T22:26:43Z","timestamp":1578695203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X98002019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,10]]},"references-count":30,"alternative-id":["S0022510X98002019"],"URL":"https:\/\/doi.org\/10.1016\/s0022-510x(98)00201-9","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[1998,10]]}}}